Figure 3.
Transfusion of KELlo, KELmed, and KELhiRBCs into anti-KEL antibody immunized recipients results in antigen modulation. (A-D) RBCs with KELlo (green), KELmed (blue), and KELhi (red) were monitored posttransfusion for IgG deposition over time by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into PBS-treated control recipients (A) or recipients that possessed low (B), medium (med) (C), or high (hi) (D) αKEL levels. (E-H) RBCs with KELlo (green), KELmed (blue), and KELhi (red) were examined for total KEL antigen detected by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into PBS-treated (E) control recipients or recipients with low (F), medium (med) (G), or high (hi) (H) αKEL levels. Error bars represent mean ± SEM. n = 5-7 mice per group. Each panel represents data reproduced 3 times. *Significance indicated vs value at 10 minutes posttransfusion. P < .05.